| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Parish Anesthesia Associates is a Metairie, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medicalsupply.Net is a Glendora, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Floyd Lee Locums provides an elite concierge experience to physicians, CRNAs, nurse practitioners, physician assistants, and other healthcare providers searching for new career opportunities. Founded by industry veterans Matt Floyd and Natasha Lee, Floyd Lee Locums is a locum tenens healthcare staffing organization with over 60 years of combined experience.
DMS Health Group is a Fargo, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.